Article Information
History
- October 2, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Division of Gastroenterology, Department of Medicine, University of California, San Francisco, CA
- 2Bakar Computational Health Sciences Institute, University of California, 550 16th Street, San Francisco, CA
- 3Department of Pediatrics, University of California, San Francisco, CA
- 4Center for Data-Driven Insights and Innovation, University of California Health, Oakland, CA
- ↵*Corresponding Author: Atul J. Butte. 550 16th Street, 4th Floor Box 0110, San Francisco, CA 94158-2549. tel: 415·514·0511. email: atul.butte{at}ucsf.edu
Posted October 02, 2019.
A Comparison of the Randomized Clinical Trial Efficacy and Real-World Effectiveness of Tofacitinib for the Treatment of Inflammatory Bowel Disease: A Cohort Study
